NASDAQ
No price data available for this timeframe.
Alignment Healthcare, Inc. (ALHC) has a consensus Buy rating from 16 analysts with an average price target of $24.33, representing +18.1% upside from the current price of $20.60.
| Date | Analyst | Firm | Target | Price | Upside |
|---|---|---|---|---|---|
| May 26, 2026 | Unknown | Barclays | $16.00 | $16.01 | -0.06% |
| May 7, 2026 | Unknown | Raymond James | $22.00 | $18.25 | +20.55% |
| May 1, 2026 | Jonathan Yong | UBS | $22.00 | $19.83 | +10.94% |
| May 1, 2026 | Unknown | Barclays | $19.00 | $22.54 |
May 26, 2026 | Maintained | Barclays | Equal Weight | Equal Weight |
May 1, 2026 | Maintained | UBS | Neutral | Neutral |
May 1, 2026 | Maintained | Barclays | Equal Weight | Equal Weight |
Feb 5, 2026 | Maintained | JP Morgan | Overweight | Overweight |
Jan 16, 2026 | Maintained | TD Cowen | Buy | Buy |
| Jan 30, 2026 | Unknown | Robert W. Baird | $28.00 | $22.50 | +24.44% |